Edible Red Seaweed Ameliorates High-Fat Diet-Induced Metabolic Diseases in Mice.

Metabolic diseases, including obesity, diabetes, and fatty liver disease, are dramatically increasing around the world. Seaweed is low in calories and rich in many active ingredients that are necessary for maintaining good health, and is expected to be effective for preventing metabolic diseases. The purpose of this study was to examine the effects of a traditional Japanese edible seaweed () on obesity, using a mouse model.

The anti-obesity and anti-diabetic effects of the edible seaweed (Postels et Ruprecht) J. Agardh in mice fed a high-fat diet.

Obesity and diabetes are serious, chronic medical conditions associated with a wide range of life-threatening conditions. The aim of this study was to investigate the effects of the edible red seaweed (Postels et Ruprecht) J. Agardh () on the development of obesity, diabetes and related metabolic diseases in mice.

Edible red seaweed Campylaephora hypnaeoides J. Agardh alleviates obesity and related metabolic disorders in mice by suppressing oxidative stress and inflammatory response.

Background: The obesity epidemic has become a serious public health problem in many countries worldwide. Seaweed has few calories and is rich in active nutritional components necessary for health promotion and disease prevention. The aim of this study was to investigate the effects of the Campylaephora hypnaeoides J.

The Edible Brown Seaweed (Turner) C. Agardh Ameliorates High-Fat Diet-Induced Obesity, Diabetes, and Hepatic Steatosis in Mice.

(Turner) C. Agardh () is edible brown seaweed that grows along the coast of East Asia and has been traditionally used as a folk medicine and a local food. In this study, we evaluated the effects of on the development of obesity and related metabolic disorders in C57BL/6J mice fed a high-fat diet.